Intermittent itraconazole therapy for preventing asthma exacerbations
Phase 2
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000006311
- Lead Sponsor
- Respiratory Medicine, Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients having abnormal shadow on chest X-ray indicative of cough aetiology 2)Patients having wheezing audible 3)Patients having obstructive disorders in pulmonary function testing 4)Patients having severe complications 5)Patients having pulmonary tuberculosis 6)Patients without agreement 7)Patients being pregnant, possible pregnant or breast-feeding a baby 8)Patients judged inappropriate by attending physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Comparison of frequency of asthma attack during next one year between 2 groups. 2.Comparison of frequency of asthma attack between last year and this year. 3.Statistical analysis of two groups against the results of skin reaction tests of Schizophyllum commune.
- Secondary Outcome Measures
Name Time Method 1.Comparison of allergological changes and clinical courses.